{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T08:28:25Z","timestamp":1788683305565,"version":"build-2803163510"},"reference-count":109,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3987,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:sec>\n            <jats:title>Key Points<\/jats:title>\n          <\/jats:sec>","DOI":"10.1002\/lt.20261","type":"journal-article","created":{"date-parts":[[2004,9,20]],"date-time":"2004-09-20T22:00:59Z","timestamp":1095717659000},"page":"S39-S53","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":66,"title":["Liver transplantation in patients with HIV infection"],"prefix":"10.1097","volume":"10","author":[{"given":"John","family":"Fung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan","family":"Eghtesad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusum","family":"Patel-Tom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"DeVera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Ragni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20250326","first-page":"119","article-title":"1993 Revised Classification System for HIV Infection and Expanded Surveillance of Definition for AIDS Among Adolescents and Adults.","volume":"31","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"R2-9-20250326","first-page":"126131","article-title":"Prevalence of HIV infection in the United States.","volume":"276","author":"Karon","year":"1996","journal-title":"JAMA"},{"key":"R3-9-20250326","doi-asserted-by":"crossref","first-page":"13291334","DOI":"10.1001\/jama.1996.03530410043031","article-title":"Survival from early, intermediate, and late stages of HIV infection.","volume":"275","author":"Enger","year":"1996","journal-title":"JAMA"},{"key":"R4-9-20250326","doi-asserted-by":"crossref","first-page":"654663","DOI":"10.7326\/0003-4819-124-7-199604010-00006","article-title":"Immunopathogenic mechanisms of HIV infection.","volume":"124","author":"Fauci","year":"1996","journal-title":"Ann Intern Med"},{"key":"R5-9-20250326","doi-asserted-by":"crossref","first-page":"946954","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4 lymphocytes as prognostic markers of HIV-1 infection.","volume":"126","author":"Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"R7-9-20250326","doi-asserted-by":"crossref","first-page":"117122","DOI":"10.1038\/373117a0","article-title":"Viral dynamics in human immunodeficiency virus type 1 infection.","volume":"373","author":"Wei","year":"1995","journal-title":"Nature"},{"key":"R8-9-20250326","first-page":"11231128","article-title":"Long-term HIV-1 infection without immunologic progression.","volume":"8","author":"Buchbinder","year":"1995","journal-title":"AIDS"},{"key":"R9-9-20250326","doi-asserted-by":"crossref","first-page":"209216","DOI":"10.1056\/NEJM199501263320402","article-title":"Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.","volume":"332","author":"Pantaleo","year":"1995","journal-title":"N Engl J Med"},{"key":"R10-9-20250326","doi-asserted-by":"crossref","first-page":"10811090","DOI":"10.1056\/NEJM199610103351501","article-title":"A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.","volume":"335","author":"Hammer","year":"1996","journal-title":"N Engl J Med"},{"key":"R11-9-20250326","doi-asserted-by":"crossref","first-page":"643676","DOI":"10.1086\/515179","article-title":"Guide to major clinical trials of antiretroviral therapy in human immunodeficiency virus-infected patients: Protease inhibitors, non-nucleoside reverse transcriptase inhibitors, and nucleotide reverse transcriptase inhibitors.","volume":"28","author":"Tavel","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R12-9-20250326","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.","volume":"135","author":"Murphy","year":"2001","journal-title":"Ann Intern Med"},{"key":"R13-9-20250326","doi-asserted-by":"crossref","first-page":"853860","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R14-9-20250326","doi-asserted-by":"crossref","first-page":"725733","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.","volume":"337","author":"Hammer","year":"1997","journal-title":"N Engl J Med"},{"key":"R15-9-20250326","doi-asserted-by":"crossref","first-page":"112116","DOI":"10.1126\/science.277.5322.112","article-title":"Positive effects of combined antiretroviral therapy on CD4 T cell homeostasis and function in advanced HIV disease.","volume":"277","author":"Autran","year":"1997","journal-title":"Science"},{"key":"R16-9-20250326","doi-asserted-by":"crossref","first-page":"83518355","DOI":"10.1073\/pnas.89.17.8351","article-title":"Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK506.","volume":"89","author":"Karpas","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R17-9-20250326","doi-asserted-by":"crossref","first-page":"374383","DOI":"10.1086\/514054","article-title":"Cyclosporin A modulation of early virologic and immunologic events during primary simian immunodeficiency virus infection in rhesus monkeys.","volume":"176","author":"Martin","year":"1997","journal-title":"J Infect Dis"},{"key":"R18-9-20250326","doi-asserted-by":"crossref","first-page":"181198","DOI":"10.1016\/0090-1229(88)90071-2","article-title":"Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease.","volume":"47","author":"Andrieu","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"key":"R19-9-20250326","first-page":"229234","article-title":"Long-term follow-up of HIV positive asymptomatic patients having received cyclosporin A.","volume":"374","author":"Levy","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"R20-9-20250326","doi-asserted-by":"crossref","first-page":"362370","DOI":"10.1097\/00126334-199908150-00002","article-title":"Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity.","volume":"21","author":"Margolis","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R21-9-20250326","doi-asserted-by":"crossref","first-page":"762768","DOI":"10.1038\/77489","article-title":"Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo.","volume":"6","author":"Chapuis","year":"2000","journal-title":"Nat Med"},{"key":"R22-9-20250326","doi-asserted-by":"crossref","first-page":"199206","DOI":"10.1001\/jama.288.2.199","article-title":"Hepatitis C and progression of HIV disease.","volume":"288","author":"Sulkowski","year":"2002","journal-title":"JAMA"},{"key":"R23-9-20250326","doi-asserted-by":"crossref","first-page":"150154","DOI":"10.1086\/520144","article-title":"Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): The effect of coinfection on survival.","volume":"29","author":"Staples","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R24-9-20250326","first-page":"795797","article-title":"Hepatitis B virus infection in the acquired immunodeficiency syndrome.","volume":"101","author":"Rusti","year":"1984","journal-title":"Ann Intern Med"},{"key":"R25-9-20250326","doi-asserted-by":"crossref","first-page":"11121115","DOI":"10.1086\/319273","article-title":"Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection.","volume":"183","author":"Ragni","year":"2001","journal-title":"J Infect Dis"},{"key":"R26-9-20250326","first-page":"602610","article-title":"Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study.","volume":"6","author":"Eyster","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R27-9-20250326","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/S0168-8278(97)80274-7","article-title":"Hepatitis B and C in HIV infected patients. Prevalence and prognostic value.","volume":"27","author":"Ockenga","year":"1997","journal-title":"J Hepatol"},{"key":"R28-9-20250326","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-8278(97)80001-3","article-title":"Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis.","volume":"26","author":"Soto","year":"1997","journal-title":"J Hepatol"},{"key":"R29-9-20250326","doi-asserted-by":"crossref","first-page":"240247","DOI":"10.1086\/321819","article-title":"Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection.","volume":"33","author":"Monga","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"R30-9-20250326","first-page":"119123","article-title":"Hepatitis C and HIV infection: Biological, clinical, and therapeutic implications.","volume":"31","author":"Soriano","year":"1999","journal-title":"J Hepatol"},{"key":"R31-9-20250326","doi-asserted-by":"crossref","first-page":"492497","DOI":"10.1086\/318501","article-title":"Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection.","volume":"32","author":"Bica","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R32-9-20250326","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1023\/A:1007506617734","article-title":"Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.","volume":"15","author":"Soriano","year":"1999","journal-title":"Eur J Epidemiol"},{"key":"R33-9-20250326","doi-asserted-by":"crossref","first-page":"211217","DOI":"10.1097\/00126334-200007010-00003","article-title":"Mortality from liver disease in patients with HIV infection: A cohort study.","volume":"24","author":"Puoti","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R34-9-20250326","doi-asserted-by":"crossref","first-page":"475484","DOI":"10.1016\/S0168-8278(86)80059-9","article-title":"The spectrum of liver disease in the acquired immunodeficiency syndrome.","volume":"2","author":"Gordon","year":"1986","journal-title":"J Hepatol"},{"key":"R35-9-20250326","doi-asserted-by":"crossref","first-page":"14121414","DOI":"10.1016\/S0140-6736(00)04579-7","article-title":"Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia.","volume":"357","author":"Carr","year":"2001","journal-title":"Lancet"},{"key":"R36-9-20250326","doi-asserted-by":"crossref","first-page":"156160","DOI":"10.1016\/S0168-8278(99)80020-8","article-title":"Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion.","volume":"30","author":"Chariot","year":"1999","journal-title":"J Hepatol"},{"key":"R37-9-20250326","doi-asserted-by":"crossref","first-page":"311317","DOI":"10.1002\/hep.20074","article-title":"Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.","volume":"39","author":"Walker","year":"2004","journal-title":"Hepatology"},{"key":"R38-9-20250326","doi-asserted-by":"crossref","first-page":"776781","DOI":"10.1258\/09564620360719840","article-title":"Risk and determinants of developing severe liver toxicity during therapy with nevirapine- and efavirenz-containing regimens in HIV-infected patients.","volume":"14","author":"Ena","year":"2003","journal-title":"Int J STD AIDS"},{"key":"R39-9-20250326","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/S0168-8278(05)80518-5","article-title":"AIDS-related cholangitis: Diagnostic features and course in 15 patients.","volume":"17","author":"Bouche","year":"1993","journal-title":"J Hepatol"},{"key":"R40-9-20250326","doi-asserted-by":"crossref","first-page":"9599","DOI":"10.1056\/NEJM199301143280204","article-title":"Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis.","volume":"328","author":"Pol","year":"1993","journal-title":"N Engl J Med"},{"key":"R41-9-20250326","doi-asserted-by":"crossref","first-page":"329337","DOI":"10.1016\/S1568-9972(02)00086-1","article-title":"HIV and autoimmunity.","volume":"1","author":"Zandman-Goddard","year":"2002","journal-title":"Autoimmun Rev"},{"key":"R42-9-20250326","doi-asserted-by":"crossref","first-page":"16201624","DOI":"10.1016\/S0140-6736(97)10290-2","article-title":"Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders.","volume":"351","author":"Mason","year":"1998","journal-title":"Lancet"},{"key":"R43-9-20250326","doi-asserted-by":"crossref","first-page":"11871191","DOI":"10.1097\/00007890-199805150-00008","article-title":"Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation?","volume":"65","author":"Spital","year":"1998","journal-title":"Transplantation"},{"key":"R44-9-20250326","first-page":"14561460","article-title":"Cyclosporine-induced deterioration in patients with AIDS.","volume":"140","author":"Phillips","year":"1989","journal-title":"Can Med Assoc J"},{"key":"R45-9-20250326","doi-asserted-by":"crossref","first-page":"622623","DOI":"10.1093\/clinids\/14.2.622","article-title":"Immunosuppression in HIV-infected transplant recipients.","volume":"14","author":"Baum","year":"1992","journal-title":"Clin Infect Dis"},{"key":"R46-9-20250326","doi-asserted-by":"crossref","first-page":"95103","DOI":"10.1097\/00007890-199301000-00019","article-title":", Offermann G, Keller F, Bennhold I, Lage-Stehr J, Krause PH, Mihatsch MJ: The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantationdata on four cases and review of the literature.","volume":"55","author":"Schwarz","year":"1993","journal-title":"Transplantation"},{"key":"R47-9-20250326","doi-asserted-by":"crossref","first-page":"134140","DOI":"10.1097\/00007890-198901000-00030","article-title":"Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986.","volume":"47","author":"Dummer","year":"1989","journal-title":"Transplantation"},{"key":"R48-9-20250326","doi-asserted-by":"crossref","first-page":"354358","DOI":"10.1097\/00007890-199002000-00025","article-title":"Transplantation in HIV patients.","volume":"49","author":"Tzakis","year":"1990","journal-title":"Transplantation"},{"key":"R50-9-20250326","first-page":"18861887","article-title":"Organ transplantation in HIV-positive patients with hemophilia.","volume":"322","author":"Ragni","year":"1990","journal-title":"N Engl J Med"},{"key":"R51-9-20250326","doi-asserted-by":"crossref","first-page":"537547","DOI":"10.1093\/clinids\/13.4.537","article-title":"Human immunodeficiency virus infection in patients with solid-organ transplants: Report of five cases and review.","volume":"13","author":"Erice","year":"1991","journal-title":"Rev Infect Dis"},{"key":"R52-9-20250326","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0140-6736(91)91414-P","article-title":"Outcome of HIV infection in transplant patient on cyclosporin. letter.","volume":"337","author":"Jacobson","year":"1991","journal-title":"Lancet"},{"key":"R53-9-20250326","doi-asserted-by":"crossref","first-page":"744749","DOI":"10.1136\/gut.42.5.744","article-title":"Outcome of orthotopic liver transplantation in patients with haemophilia.","volume":"42","author":"Gordon","year":"1998","journal-title":"Gut"},{"key":"R54-9-20250326","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0140-6736(91)90795-Q","article-title":"Long-term survival without immunosuppression in HIV-positive liver-graft recipients.","volume":"337","author":"Vanhems","year":"1991","journal-title":"Lancet"},{"key":"R55-9-20250326","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1034\/j.1600-6143.2001.010104.x","article-title":"Transplantation in the HIV patient.","volume":"1","author":"Kuo","year":"2001","journal-title":"Am J Transplant"},{"key":"R56-9-20250326","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0168-8278(03)00213-7","article-title":"Liver transplantation in patients with HIV infection.","volume":"39","author":"Samuel","year":"2003","journal-title":"J Hepatol"},{"key":"R57-9-20250326","doi-asserted-by":"crossref","first-page":"17731778","DOI":"10.1001\/archinte.163.15.1773","article-title":"Key clinical, ethical, and policy issues in the evaluation of the safety and efficacy of solid organ transplantation in HIV-infected patients.","volume":"163","author":"Roland","year":"2003","journal-title":"Arch Intern Med"},{"key":"RU58-9-20250326","doi-asserted-by":"crossref","first-page":"870875","DOI":"10.1136\/gut.39.6.870","article-title":"Liver transplantation for haemophiliacs with hepatitis C cirrhosis.","volume":"39","author":"McCarthy","year":"1996","journal-title":"Gut"},{"issue":"suppl 1","key":"RU59-9-20250326","first-page":"S212S220","article-title":"Post-transplant primary disease does not influence 6-year survival after liver transplantation beyond 1 year.","volume":"11","author":"Caccamo","year":"1998","journal-title":"Transpl Int"},{"key":"RU60-9-20250326","doi-asserted-by":"crossref","first-page":"11131114","DOI":"10.1182\/blood.V93.3.1113","article-title":"Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome.","volume":"93","author":"Ragni","year":"1999","journal-title":"Blood"},{"key":"R61-9-20250326","doi-asserted-by":"crossref","first-page":"307309","DOI":"10.1097\/00007890-199907270-00027","article-title":"Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels.","volume":"68","author":"Sheikh","year":"1999","journal-title":"Transplantation"},{"key":"RU62-9-20250326","doi-asserted-by":"crossref","first-page":"21942195","DOI":"10.1097\/00007890-200005270-00041","article-title":"Interaction between nelfinavir and tacrolimus after orthotopic liver transplantation in a patient coinfected with HIV and Hepatiitis C virus (HCV).","volume":"69","author":"Schvarcz","year":"2000","journal-title":"Transplantation"},{"key":"RU63-9-20250326","first-page":"523526","article-title":"Orthotopic liver transplantation in a 33-year-old patient with fulminant hepatitis B and HIV infection.","volume":"125","author":"Schliefer","year":"2000","journal-title":"Dtsch Med Wochenschr"},{"key":"RU64-9-20250326","doi-asserted-by":"crossref","first-page":"16841688","DOI":"10.1097\/00007890-200111270-00020","article-title":"Liver transplantation in adults coinfected with HIV.","volume":"72","author":"Prachalias","year":"2001","journal-title":"Transplantation"},{"key":"R65-9-20250326","doi-asserted-by":"crossref","first-page":"14121420","DOI":"10.1086\/379254","article-title":"Survival of human immunodeficiency virus-infected liver transplant recipients.","volume":"188","author":"Ragni","year":"2003","journal-title":"J Infect Dis"},{"key":"RU66-9-20250326","doi-asserted-by":"crossref","first-page":"291292","DOI":"10.1097\/00002030-200101260-00029","article-title":"Liver transplantation for an HIV-positive patient in the era of highly active antiretroviral therapy.","volume":"15","author":"Gow","year":"2001","journal-title":"AIDS"},{"key":"RU67-9-20250326","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM200112133452417","article-title":"Fibrosing cholestatic hepatitis after liver transplantation in a patient with Hepatitis C and HIV infection. letter.","volume":"345","author":"Tolan","year":"2001","journal-title":"N Engl J Med"},{"key":"RU68-9-20250326","doi-asserted-by":"crossref","first-page":"16551656","DOI":"10.1097\/00007890-200212150-00031","article-title":"Living donor liver transplantation in an HIV-positive patient with hemophilia.","volume":"74","author":"Sugawara","year":"2002","journal-title":"Transplantation"},{"key":"RU69-9-20250326","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0025-7753(02)73506-9","article-title":"Liver transplantation in a patient infected by human immunodeficiency virus.","volume":"119","author":"Rafecas","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"RU70-9-20250326","doi-asserted-by":"crossref","first-page":"239247","DOI":"10.1053\/jlts.2003.50054","article-title":"Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.","volume":"9","author":"Neff","year":"2003","journal-title":"Liver Transpl"},{"key":"RU71-9-20250326","doi-asserted-by":"crossref","first-page":"370375","DOI":"10.1097\/01.TP.0000075973.73064.A6","article-title":"Kidney and liver transplantation in human immunodeficiency virus-infected patients: A pilot safety and efficacy study.","volume":"76","author":"Stock","year":"2003","journal-title":"Transplantation"},{"key":"RU72-9-20250326","doi-asserted-by":"crossref","first-page":"18461847","DOI":"10.1016\/S0041-1345(03)00635-3","article-title":"Liver transplantation in a patient coinfected with human immunodeficiency virus and hepatitis C virus.","volume":"35","author":"Gonzalez Alonso","year":"2003","journal-title":"Transplant Proc"},{"key":"RU73-9-20250326","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1089\/08892220360473925","article-title":"Follow-up of a antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection.","volume":"19","author":"Nowak","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"RU74-9-20250326","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0041-1345(02)03874-5","article-title":"Liver transplantation in a patient with human immunodeficiency virus infection: A case report.","volume":"35","author":"Jeng","year":"2003","journal-title":"Transplant Proc"},{"key":"RU75-9-20250326","first-page":"C6","article-title":"Is anti-retroviral treatment after transplantation in HIV positive patients always necessary? abstract no. 14. 10th Congress of the International Liver Transplantation Society, Kyoto, Japan, 10 June 2004.","volume":"10","author":"Boschetto","year":"2004","journal-title":"Liver Transpl"},{"key":"R76-9-20250326","doi-asserted-by":"crossref","first-page":"425429","DOI":"10.1097\/01.TP.0000046943.35335.18","article-title":"Review of solid-organ transplantation in HIV-infected patients.","volume":"75","author":"Roland","year":"2003","journal-title":"Transplantation"},{"key":"R77-9-20250326","doi-asserted-by":"crossref","first-page":"520525","DOI":"10.1002\/lt.500050602","article-title":"Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin.","volume":"5","author":"Yoshida","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"R78-9-20250326","first-page":"889896","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation.","volume":"122","author":"Berenger","year":"2002","journal-title":"Gastroenterology"},{"key":"R79-9-20250326","first-page":"673684","article-title":"HCV-related fibrosis progression following liver transplantation: Increase in recent years.","volume":"32","author":"Berenguer","year":"2000","journal-title":"J Hepatol"},{"key":"R80-9-20250326","doi-asserted-by":"crossref","first-page":"10671078","DOI":"10.1016\/0092-8674(93)90637-6","article-title":"Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B.","volume":"73","author":"Luban","year":"1993","journal-title":"Cell"},{"key":"R81-9-20250326","doi-asserted-by":"crossref","first-page":"53815385","DOI":"10.1073\/pnas.92.12.5381","article-title":"Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A.","volume":"92","author":"Bartz","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R82-9-20250326","doi-asserted-by":"crossref","first-page":"825835","DOI":"10.1099\/0022-1317-78-4-825","article-title":"The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells.","volume":"78","author":"Mlynar","year":"1997","journal-title":"J Gen Virol"},{"key":"R83-9-20250326","doi-asserted-by":"crossref","first-page":"356362","DOI":"10.1097\/00126334-200204010-00005","article-title":"Placebo-controlled trial of cyclosporin-A in HIV-1 disease: Implications for solid organ transplantation.","volume":"29","author":"Calabrese","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R84-9-20250326","doi-asserted-by":"crossref","first-page":"854859","DOI":"10.1093\/clinids\/19.5.854","article-title":"An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1.","volume":"19","author":"Bouscarat","year":"1994","journal-title":"Clin Infect Dis"},{"key":"R85-9-20250326","doi-asserted-by":"crossref","first-page":"321327","DOI":"10.1097\/00002030-200102160-00004","article-title":"Placebo-controlled trial of prednisone in advanced HIV-1 infection.","volume":"15","author":"McComsey","year":"2001","journal-title":"AIDS"},{"key":"R86-9-20250326","doi-asserted-by":"crossref","first-page":"281286","DOI":"10.1097\/00126334-200303010-00006","article-title":"A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm3.","volume":"32","author":"Wallis","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R87-9-20250326","doi-asserted-by":"crossref","first-page":"423434","DOI":"10.1097\/00126334-200104150-00004","article-title":"A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection.","volume":"26","author":"Coull","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R88-9-20250326","doi-asserted-by":"crossref","first-page":"453458","DOI":"10.1056\/NEJM198308253090803","article-title":"Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.","volume":"309","author":"Lane","year":"1983","journal-title":"N Engl J Med"},{"key":"R89-9-20250326","doi-asserted-by":"crossref","first-page":"561566","DOI":"10.1172\/JCI115621","article-title":"Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation.","volume":"89","author":"Shirai","year":"1992","journal-title":"J Clin Invest"},{"issue":"suppl 8","key":"R90-9-20250326","first-page":"290","article-title":"Unexpectedly high rejection rates in HIV-positive recipients of renal transplants. abstract no. 481. 2004 American Transplant Congress, Boston, MA, 16 May 2004.","volume":"4","author":"Hirose","year":"2004","journal-title":"Am J Transplant"},{"key":"R91-9-20250326","doi-asserted-by":"crossref","first-page":"631633","DOI":"10.1034\/j.1600-6143.2003.00119.x","article-title":"Kidney-pancreas transplantation in a long-term non-progressor HIV-infected recipient.","volume":"3","author":"Toso","year":"2003","journal-title":"Am J Transplant"},{"key":"R92-9-20250326","doi-asserted-by":"crossref","first-page":"13841386","DOI":"10.1097\/00007890-199811270-00020","article-title":"Long-term nonprogressive human immunodeficiency virus-1 infection in a kidney allograft recipient.","volume":"66","author":"Purgus","year":"1998","journal-title":"Transplantation"},{"key":"R93-9-20250326","doi-asserted-by":"crossref","first-page":"841845","DOI":"10.1053\/jlts.2002.34880","article-title":"The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.","volume":"8","author":"Jain","year":"2002","journal-title":"Liver Transpl"},{"key":"R94-9-20250326","doi-asserted-by":"crossref","first-page":"954960","DOI":"10.1053\/jlts.2003.50171","article-title":"Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients.","volume":"9","author":"Jain","year":"2003","journal-title":"Liver Transpl"},{"key":"R95-9-20250326","first-page":"646648","article-title":"Anti-retrovirals and immunosuppressive drug interactions in a HIV-positive patient after liver transplantation.","volume":"51","author":"Antonini","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"R96-9-20250326","doi-asserted-by":"crossref","first-page":"914915","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00022","article-title":"Pharmacokinetic interaction between saquinavir and cyclosporine. letter.","volume":"129","author":"Brinkman","year":"1998","journal-title":"Ann Intern Med"},{"key":"R97-9-20250326","doi-asserted-by":"crossref","first-page":"838840","DOI":"10.1053\/jlts.2002.34921","article-title":"Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: A case report.","volume":"8","author":"Jain","year":"2002","journal-title":"Liver Transpl"},{"key":"R98-9-20250326","doi-asserted-by":"crossref","first-page":"699702","DOI":"10.1002\/lt.20109","article-title":"Mitochondrial toxicity associated with HAART following liver transplantation in an HIV-infected recipient.","volume":"10","author":"Antoniades","year":"2004","journal-title":"Liver Transpl"},{"key":"R99-9-20250326","doi-asserted-by":"crossref","first-page":"187203","DOI":"10.1034\/j.1399-3062.1999.010307.x","article-title":"Prevention and treatment of cytomegalovirus infection in organ transplant recipients.","volume":"1","author":"Kusne","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"R100-9-20250326","doi-asserted-by":"crossref","first-page":"11531183","DOI":"10.2165\/00003495-200161080-00016","article-title":"Ganciclovir: An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.","volume":"61","author":"McGavin","year":"2001","journal-title":"Drugs"},{"key":"R101-9-20250326","doi-asserted-by":"crossref","first-page":"279287","DOI":"10.1016\/S1386-6532(01)00200-1","article-title":"Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy.","volume":"22","author":"Price","year":"2001","journal-title":"J Clin Virol"},{"key":"R102-9-20250326","doi-asserted-by":"crossref","first-page":"177181","DOI":"10.1097\/00007890-200107270-00001","article-title":"Solid organ transplantation in patients with HIV infection.","volume":"72","author":"Gow","year":"2001","journal-title":"Transplantation"},{"key":"R103-9-20250326","doi-asserted-by":"crossref","first-page":"32793280","DOI":"10.1093\/ndt\/13.12.3279","article-title":"Kaposis sarcoma after renal transplantationdisappearance after reduction of immunosuppression and reappearance 7 years later after start of mycophenolate mofetil treatment.","volume":"13","author":"Gomez","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"R104-9-20250326","doi-asserted-by":"crossref","first-page":"463466","DOI":"10.1097\/00007890-199608270-00007","article-title":"Renal transplantation exposes patients with previous Kaposis sarcoma to a high risk of recurrence.","volume":"62","author":"Doutrelepont","year":"1996","journal-title":"Transplantation"},{"key":"R105-9-20250326","doi-asserted-by":"crossref","first-page":"28952902","DOI":"10.1097\/00002030-200012220-00011","article-title":"Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.","volume":"14","author":"den Brinker","year":"2000","journal-title":"AIDS"},{"key":"R106-9-20250326","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/jhep.2002.32094","article-title":"Risk of HAART therapy in hepatitis C.","volume":"35","author":"McGovern","year":"2002","journal-title":"Hepatology"},{"key":"R107-9-20250326","first-page":"16331639","article-title":"Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression.","volume":"5","author":"Abbott","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R108-9-20250326","doi-asserted-by":"crossref","first-page":"480482","DOI":"10.1159\/000169147","article-title":"Long-term survival in an HIV-infected renal transplant recipient.","volume":"17","author":"Ahuja","year":"1997","journal-title":"Am J Nephrol"},{"key":"R109-9-20250326","doi-asserted-by":"crossref","first-page":"144147","DOI":"10.1034\/j.1399-3062.2002.01009.x","article-title":"Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: An historical cohort analysis of the United States Renal Data System.","volume":"4","author":"Swanson","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"R110-9-20250326","doi-asserted-by":"crossref","first-page":"23232328","DOI":"10.1056\/NEJMoa022935","article-title":"Successful cardiac transplantation in an HIV-1-infected patient with advanced disease.","volume":"348","author":"Calabrese","year":"2003","journal-title":"N Engl J Med"},{"key":"R111-9-20250326","doi-asserted-by":"crossref","first-page":"284287","DOI":"10.1056\/NEJMsb020632","article-title":"Solid-organ transplantation in HIV-infected patients.","volume":"347","author":"Halpern","year":"2002","journal-title":"N Engl J Med"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.20261","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200410001-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T13:46:23Z","timestamp":1743255983000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200410001-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":109,"journal-issue":{"issue":"Supplement 10","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.20261","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}